Quick Facts

• Many cardiologists in their mid-30s take statins even with normal cholesterol levels as preventive medicine
• New 2026 guidelines recommend considering statin treatment starting at age 30 for high-risk adults
• The updated PREVENT risk calculator is 40-50% more accurate than previous assessment tools

Heart doctors are practicing what they preach when it comes to cardiovascular prevention. Many cardiologists in their mid-30s are taking statins despite having normal cholesterol levels, a trend that reflects major changes in how the medical community approaches heart disease prevention.

Dr. Christopher Kelly, a cardiologist and Men’s Health advisor, noticed this pattern among his colleagues. When Dr. C. Noel Bairey Merz asks audiences of 100 cardiologists how many take statins, almost every hand goes up.

This shift stems from new 2026 cardiovascular guidelines that lower treatment thresholds significantly. The updated recommendations suggest adults should assess cholesterol risk at younger ages and consider treatment starting at age 30 for those at high long-term risk.

The guidelines introduce the PREVENT risk calculator, which replaces older assessment tools that overestimated heart attack and stroke risk by 40-50%. This new calculator provides more accurate risk predictions for younger adults.

“Traditionally, statins were viewed as purely cholesterol-lowering drugs,” explains Johns Hopkins cardiologist Michael Blaha. “But we’ve learned that they also benefit people with lower levels of cholesterol who are at a high risk of heart disease.”

The concept of “LDL years” drives this preventive approach. This measures how long arteries are exposed to elevated LDL cholesterol. Dr. Adedapo Iluyomade of Miami Cardiac & Vascular Institute notes that more exposure years increase heart disease risk regardless of current cholesterol levels.

Research shows statins provide benefits beyond cholesterol reduction. They stabilize arterial plaque and reduce atherosclerotic cardiovascular disease risk by about 26% even when LDL levels aren’t extremely high.

The new guidelines consider lowering the treatment threshold to a 3% risk of heart attack or stroke over 10 years. This would qualify roughly the same number of people for statin therapy as current guidelines but identify them earlier in life.

More than 200 million people worldwide take statins, with 47 million Americans using cholesterol medication daily. The global statin market was valued at $16.32 billion in 2025 and is expected to reach $20.07 billion by 2032.

Doctors now use comprehensive risk assessments beyond cholesterol numbers. These include blood pressure, blood glucose, body mass index, and tests like coronary calcium scans that detect plaque buildup.

Timothy Anderson, a primary care physician at the University of Pittsburgh Medical Center, explains the rationale: “A real focus of the guidelines is identifying and treating high cholesterol earlier on, out of the hypothesis that long-term exposure to high cholesterol may have greater risks than short-term exposure.”

This preventive approach represents a fundamental shift from treating high cholesterol reactively to preventing cardiovascular disease proactively. For busy professionals, this means earlier conversations with doctors about cardiovascular risk assessment, even with normal cholesterol levels.

Read more: Many Cardiologists Take This Cheap Drug Years Before Heart Problems Ever Show Up